Article Details
Retrieved on: 2018-02-21 21:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Kallyope Inc., a NYC-based biotechnology company focused on identifying therapeutic opportunities involving the gut-brain axis, raised $66m in Series B financing. Backers included <b>Lux Capital</b>, The Column Group, Polaris Partners, Illumina Ventures, and Alexandria Venture Investments as well as new ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here